|
India News Releases
|
(India.CityRegions.Com, June 17, 2017 ) Anaplastic astrocytoma is a grade III tumor. It accounts for two percent of all brain tumors. It is a type of glioma that develops from star-shaped glial cells (astrocytes) , which support nerve cells. Anaplastic astrocytoma grows faster and more aggressively than grade II astrocytomas. The tumor cells are not uniform in appearance and invade neighboring tissue. Symptoms include headache, weakness, clumsiness, difficulty walking and seizures. Anaplastic astrocytoma is common among men and women in their thirties to fifties and is more common in men than women. Treatment of anaplastic astrocytoma depends on the location of the tumor and how far it has progressed and usually involves surgery and radiation therapy, with chemotherapy during or following radiation.
Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Anaplastic Astrocytoma - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Anaplastic Astrocytoma (Oncology) , complete with analysis by stage of development, drug target, mechanism of action (MoA) , route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Anaplastic Astrocytoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Anaplastic Astrocytoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I and Unknown stages are 4, 8, 11 and 1 respectively. Similarly, the Universities portfolio in Phase II and Phase I stages comprises 1 and 2 molecules, respectively.
Anaplastic Astrocytoma (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
For more information about this report at http://www.reportsweb.com/anaplastic-astrocytoma-pipeline-review-h2-2017
Report Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Anaplastic Astrocytoma (Oncology) . - The pipeline guide reviews pipeline therapeutics for Anaplastic Astrocytoma (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources. - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. - The pipeline guide reviews key companies involved in Anaplastic Astrocytoma (Oncology) therapeutics and enlists all their major and minor projects. - The pipeline guide evaluates Anaplastic Astrocytoma (Oncology) therapeutics based on mechanism of action (MoA) , drug target, route of administration (RoA) and molecule type. - The pipeline guide encapsulates all the dormant and discontinued pipeline projects. - The pipeline guide reviews latest news related to pipeline therapeutics for Anaplastic Astrocytoma (Oncology)
Request a sample copy at http://www.reportsweb.com/inquiry&RW0001834368/sample
Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies. - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. - Find and recognize significant and varied types of therapeutics under development for Anaplastic Astrocytoma (Oncology) . - Classify potential new clients or partners in the target demographic. - Develop tactical initiatives by understanding the focus areas of leading companies. - Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics. - Formulate corrective measures for pipeline projects by understanding Anaplastic Astrocytoma (Oncology) pipeline depth and focus of Indication therapeutics. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Key Company profiles
Advantagene Inc Alfa Wassermann SpA Amgen Inc AngioChem Inc Astellas Pharma Inc Bayer AG Boehringer Ingelheim GmbH Burzynski Research Institute Inc Cavion LLC Celldex Therapeutics Inc Merrimack Pharmaceuticals Inc Millennium Pharmaceuticals Inc Novartis AG Orbus Therapeutics Inc Pfizer Inc Tocagen Inc Tragara Pharmaceuticals Inc TVAX Biomedical Inc ZIOPHARM Oncology Inc
Ask for Discount at http://www.reportsweb.com/inquiry&RW0001834368/discount
List of Tables
Number of Products under Development for Anaplastic Astrocytoma, H2 2017 9 Number of Products under Development by Companies, H2 2017 11 Number of Products under Development by Companies, H2 2017 (Contd..1) , H2 2017 12 Number of Products under Development by Universities/Institutes, H2 2017 13 Products under Development by Companies, H2 2017 14 Products under Development by Companies, H2 2017 (Contd..1) , H2 2017 15 Products under Development by Universities/Institutes, H2 2017 16 Number of Products by Stage and Target, H2 2017 18 Number of Products by Stage and Target, H2 2017 (Contd..1) , H2 2017 19 Number of Products by Stage and Mechanism of Action, H2 2017 21 Number of Products by Stage and Route of Administration, H2 2017 23 Number of Products by Stage and Molecule Type, H2 2017 25 Anaplastic Astrocytoma - Pipeline by Advantagene Inc, H2 2017 26 Anaplastic Astrocytoma - Pipeline by Alfa Wassermann SpA, H2 2017 26 Anaplastic Astrocytoma - Pipeline by Amgen Inc, H2 2017 27 Anaplastic Astrocytoma - Pipeline by AngioChem Inc, H2 2017 27 Anaplastic Astrocytoma - Pipeline by Astellas Pharma Inc, H2 2017 28 Anaplastic Astrocytoma - Pipeline by Bayer AG, H2 2017 28 Anaplastic Astrocytoma - Pipeline by Boehringer Ingelheim GmbH, H2 2017 29 Anaplastic Astrocytoma - Pipeline by Burzynski Research Institute Inc, H2 2017 29 Anaplastic Astrocytoma - Pipeline by Cavion LLC, H2 2017 30 Anaplastic Astrocytoma - Pipeline by Celldex Therapeutics Inc, H2 2017 30 Anaplastic Astrocytoma - Pipeline by Merrimack Pharmaceuticals Inc, H2 2017 31 Anaplastic Astrocytoma - Pipeline by Millennium Pharmaceuticals Inc, H2 2017 32 Anaplastic Astrocytoma - Pipeline by Novartis AG, H2 2017 32 Anaplastic Astrocytoma - Pipeline by Orbus Therapeutics Inc, H2 2017 33 Anaplastic Astrocytoma - Pipeline by Pfizer Inc, H2 2017 33 Anaplastic Astrocytoma - Pipeline by Tocagen Inc, H2 2017 33 Anaplastic Astrocytoma - Pipeline by Tragara Pharmaceuticals Inc, H2 2017 34 Anaplastic Astrocytoma - Pipeline by TVAX Biomedical Inc, H2 2017 34 Anaplastic Astrocytoma - Pipeline by ZIOPHARM Oncology Inc, H2 2017 35 Anaplastic Astrocytoma - Dormant Projects, H2 2017 145 Anaplastic Astrocytoma - Discontinued Products, H2 2017 146
Purchase Complete Report at http://www.reportsweb.com/buy&RW0001834368/buy/2000
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
|
|
|
India RSS Feed Marketpalce
|
India News Headlines
Daily news from India: arts, business, culture, politics, science, technology & more.
Free Sales & Marketing Magazines
Get free publications about marketing, sales and customer relations management.
Submit RSS feed on India. Have your feed on news, products or services displayed under this marketpalce and have your feed on a full page updated daily.
|
|
India Business News by Major Cities
|
|
|
Listen to GroupWeb Radio
INDIA BUSINESS TV
|